VAERS reports by lot
Sanofi Pasteur DTaP/Tdap lot U8209CB: VAERS reports
24 VAERS reports list lot U8209CB as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2025-03-10 and 2026-01-13. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).
Symptom categories in these reports
A report can mention several categories, so the counts add up to more than the number of reports.
| Category | Count | % |
|---|---|---|
| Injection-site / Local reaction | 24 | 59% |
| Allergic / Anaphylactic | 7 | 17% |
| Dermatological (non-injection-site) | 4 | 10% |
| Musculoskeletal | 2 | 5% |
| Autoimmune / Immune-mediated | 1 | 2% |
| Respiratory | 1 | 2% |
| Psychiatric / Neuropsychiatric | 1 | 2% |
| General / Systemic (non-local) | 1 | 2% |
Where reports came from
U.S. state of the reporter, where given (top 12).
| State | Reports |
|---|---|
| Colorado | 3 |
| New York | 2 |
| Georgia | 2 |
| Pennsylvania | 2 |
| Michigan | 2 |
| Montana | 2 |
| Utah | 2 |
| California | 2 |
| Washington | 1 |
| Massachusetts | 1 |
| Virginia | 1 |
| Oregon | 1 |
Reports by month received
| Month | Reports | Bar |
|---|---|---|
| 2025-03 | 6 | |
| 2025-04 | 1 | |
| 2025-05 | 2 | |
| 2025-06 | 4 | |
| 2025-07 | 4 | |
| 2025-08 | 2 | |
| 2025-09 | 1 | |
| 2025-10 | 2 | |
| 2025-11 | 1 | |
| 2026-01 | 1 |
Products recorded with this lot
- DTAPIPV — Sanofi Pasteur (24 reports)
Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.
Related
- All Sanofi Pasteur DTaP/Tdap lots with VAERS reports
- DTaP/Tdap vaccine lot number lookup
- DTaP/Tdap vaccine side effects, trials and ingredients
- Daptacel: ingredients, package insert and side effects
- Look up a lot for any vaccine
Nearby Sanofi Pasteur DTaP/Tdap lots (A–Z): U8009AB · U8015AA · U8122AA · U8232AA · U8383AB · UF456AA
Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.